Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Reata Pharma (RETA)

Reata Pharma (RETA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reata Pharma 5320 LEGACY DRIVE PLANO TX 75024 USA

P: 972-865-2219

Description:

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing and commercializing product candidates which modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress and inflammation to address the unmet medical needs of serious or life-threatening diseases. Reata Pharmaceuticals, Inc. is based in Irving, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,983,868
Shares Outstanding, K 33,228
Annual Sales, $ 26,520 K
Annual Net Income, $ -290,170 K
Last Quarter Sales, $ 2,670 K
Last Quarter Net Income, $ -186,940 K
60-Month Beta 2.52
% of Insider Shareholders 34.40%
% of Institutional Shareholders 67.13%
Float, K 21,798
% Float 65.60%

Growth:

1-Year Return 78.26%
3-Year Return 562.21%
5-Year Return 0.00%
5-Year Revenue Growth -48.95%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.91 on 02/19/20
Next Earnings Date 05/14/20
Earnings Per Share ttm -9.35
EPS Growth vs. Prev Qtr -347.73%
EPS Growth vs. Prev Year -587.21%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

RETA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -29.88
Price/Earnings to Growth N/A
Return-on-Equity % -766.88%
Return-on-Assets % -73.77%
Profit Margin % -1,094.16
Net Margin % N/A
Debt/Equity N/A
Price/Sales 186.58
Price/Cash Flow N/A
Price/Book 19.24
Book Value/Share 7.74
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar